amneal.com (AMRX): Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals generic production is based on highly automated lines with autonomous packaging. The PEG ratio confirms this efficiency, where the 0.83 metric captures the current state. Business stability is ensured by a qualified staff of chemists and strict quality control. Meanwhile, FDA licenses and proprietary manufacturing plants create a significant barrier to entry for new players.

AMRX - Amneal Pharmaceuticals, Inc. PEG Multiple over the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Amneal (AMRX)

- share price and consensus valuation forecast:
General company analysis:AMRX Amneal Corp
Mass-produced product of amneal.com

Steady demand for affordable generics and complex injectables from Amneal Pharmaceuticals (AMRX) generates a predictable cash flow, establishing a foundation for sustainable earnings growth. When analyzing growth stock attractiveness indicators, investors correlate the market value of Amneal Pharmaceuticals (AMRX) with earnings growth rates: a value below one confirms the business is undervalued relative to its expansion, signaling a margin of safety and potential for capitalization.

Competitors of Amneal Pharmaceuticals

HLN - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Kenvue Inc KVUE|Verona Pharma (VRNA) - Price to Earnings Adjusted for Growth Rate|MENS: Price/Earnings to Growth Multiple|Ligand - Company Value to Earnings Growth Ratio|PRGO: PEG Multiple|Alvotech Corp - Growth-Adjusted Payback Ratio|LQDA (Liquidia Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate glpg.com GLPG|Price/Earnings to Growth Ratio ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Growth-Adjusted Payback Ratio|PEG Multiple AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Market Cap to Earnings and Growth Ratio|SPRY - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio TBPH (Theravance Biopharma)|AQST (aquestive.com) - Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio SCPH (scPharmaceuticals, Inc.)|Price/Earnings to Growth Multiple TECX|Tonix Pharmaceuticals (TNXP) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SXTC|PEG Multiple Eupraxia Pharma (EPRX)|Price/Earnings to Growth Ratio BioHarvest Sciences Inc. BHST|EXOZ - Price/Earnings to Growth Multiple|ORMP: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate abvcpharma.com (ABVC)|Price/Earnings to Growth Ratio Cumberland Pharma|Price/Earnings to Growth Ratio QNTM|PEG Multiple FGEN|TELO (Telomir Pharma) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Rani Therapeutics Holdings RANI|SNYR - Price/Earnings to Growth Multiple|RLYB - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income lexariabioscience.com LEXX|PULM: PEG Multiple|Growth-Adjusted P/E Ratio PTHL|Price/Earnings to Growth Ratio Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Company Value to Earnings Growth Ratio|PEG Multiple IBO|Growth-Adjusted Market Cap to Net Income TNF Pharmaceuticals, Inc.|PEG Multiple YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Market Cap to Earnings and Growth Ratio|CYTO: Price/Earnings to Growth Multiple|LIPO - PEG Multiple|OptiNose, Inc. (OPTN) - Price/Earnings to Growth Ratio|PIRS - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Procaps|Price/Earnings to Growth Multiple Petros (PTPI)|Price/Earnings to Growth Ratio Qilian International Corp (QLI)|PEG Multiple acelyrin.com (SLRN)|PEG Multiple TFFP (TFF Pharmaceuticals)